OnEMI Tech board approves INR 832 Cr preferential issue to 34 investors

Fund Raising View source PDF Explain this filing

KISSHT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.1%Reaction day

₹360.45

prior close

₹358.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.6%-2.7% vs market

Other Financial Services peers, median of 87sector+0.0%-1.1% vs sector

On the reaction day the stock moved 2.7 pts less than Nifty Microcap 250 and 1.1 pts less than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

+0.1

15m

-0.9

30m

-2.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.1+1.6-2.7+0.0-1.1

Next day

+0.7+1.5-0.8-0.1+0.7

-2.1+1.9-4.0-0.6-1.5

-1.5+3.2-4.7-0.1-1.5

-6.3+1.7-8.0-0.2-6.1

-3.4+2.0-5.3-0.9-2.5

-1.8+1.4-3.2-1.4-0.3

15d

+4.0-0.8+4.8-3.2+7.3

-5.1-2.5-2.6-2.8-2.3

—————

UpDownMarket · Nifty Microcap 250Sector · Other Financial Services peers, median of 87Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

OnEMI Technology Solutions board approved a preferential issue of up to 2.64 crore equity shares at INR 314.11 per share to 34 non-promoter investors, raising about INR 832.20 crore. Premium is INR 313.11 per share. Investors include Massachusetts Institute of Technology, Axis, HDFC, Groww mutual fund schemes, Ashoka WhiteOak, and 360 One funds. EGM on October 14, 2026 for shareholder approval.

Likely market impact

Equity dilution from large preferential issue, but participation by marquee global and domestic investors signals strong institutional confidence. EGM approval pending.